Department of Psychology, University of Maryland at College Park, Biology/Psychology Building, Room 3123H, College Park, MD 20742, USA.
J Clin Child Adolesc Psychol. 2011;40(2):281-94. doi: 10.1080/15374416.2011.546043.
In this study, the authors examined the relations among clinician ratings of treatment improvement and discrepancies between parent and blinded laboratory rater reports of child social functioning administered before and after treatment for social anxiety disorder. Participants included a clinic sample of 101 children (7-16 years old; M = 11.67, SD = 2.57; 51 girls, 81% Caucasian) receiving treatment as part of a two-site controlled trial. Overall, clinician ratings reflected lack of improvement when parents reported persistent (i.e., pre- to posttreament) social functioning deficits not reported by blinded raters. However, when blinded raters reported persistent social skill deficits not reported by parents, we did not observe the same effect on clinician ratings as we did when the direction of discrepant reports was reversed. We replicated these observations in a subset of participants (n = 81) providing parent and child pre-post reports of social anxiety symptoms. These findings have implications for the interpretations of clinical ratings as "primary outcome measures" within controlled trials.
在这项研究中,作者研究了治疗改善的临床医生评分与父母和盲法实验室评分之间的差异之间的关系,这些差异涉及社交焦虑障碍治疗前后儿童社交功能的报告。参与者包括一个诊所样本,其中有 101 名儿童(7-16 岁;M=11.67,SD=2.57;51 名女孩,81%为白种人)作为两个地点对照试验的一部分接受治疗。总的来说,当父母报告盲法评估者未报告的持续(即治疗前至治疗后)社交功能缺陷时,临床医生的评分反映出缺乏改善。然而,当盲法评估者报告父母未报告的持续社交技能缺陷时,我们没有观察到与报告方向相反时对临床医生评分的相同影响。我们在提供父母和孩子社交焦虑症状的前后报告的参与者亚组(n=81)中复制了这些观察结果。这些发现对将临床评分作为对照试验中的“主要结果测量”的解释具有意义。